Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ocuphire Pharma, Inc. | Chief Executive Officer | Common Stock | 430K | $754K | $1.75 | May 17, 2024 | Direct |
Ocuphire Pharma, Inc. | Chief Executive Officer | Employee Stock Option (right to buy) | 600K | Nov 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OCUP | Ocuphire Pharma, Inc. | May 17, 2024 | 1 | $8.77K | 4 | May 21, 2024 | Chief Executive Officer |
OCUP | Ocuphire Pharma, Inc. | Mar 18, 2024 | 1 | $49.1K | 4 | Mar 20, 2024 | Chief Executive Officer |
OCUP | Ocuphire Pharma, Inc. | Nov 1, 2023 | 2 | $0 | 4 | Nov 3, 2023 | Chief Executive Officer |
OCUP | Ocuphire Pharma, Inc. | Nov 1, 2023 | 0 | $0 | 3 | Nov 3, 2023 | Chief Executive Officer |